Cargando…
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment and is crucial to cancer metastasis and relapse. Combination therapy is an effective strategy for overcoming MDR. However, the different pharmacokinetic (PK) profiles of combined drugs often undermine the combination effec...
Autores principales: | Zhang, Meng, Liu, Ergang, Cui, Yanna, Huang, Yongzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570599/ https://www.ncbi.nlm.nih.gov/pubmed/28884039 http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0054 |
Ejemplares similares
-
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
por: Xue, Xue, et al.
Publicado: (2012) -
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
por: Mir, Suhail Ahmad, et al.
Publicado: (2022) -
Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
por: Tu, Bin, et al.
Publicado: (2020) -
Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance
por: Li, Rui, et al.
Publicado: (2021) -
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
por: Yadav, Priya, et al.
Publicado: (2022)